A Pathobiological Role of the Insulin Receptor in CLL.
Source: NCBI BioProject (ID PRJNA136641)
Source: NCBI BioProject (ID PRJNA136641)
0 0
Project name: Homo sapiens
Description: Purpose: The chromosomal deletion 11q affects biology and clinical outcome in CLL but del11q-deregulated genes remain incompletely characterized.Results: We have identified differential expression of the insulin receptor (INSR) in CLL, including high-level INSR expression in the majority of CLL with del11q. High INSR mRNA expression in 11q CLL (~10-fold higher mean levels than other genomic categories) was confirmed by Q-PCR in 247 CLL cases. INSR protein measurements in 257 CLL cases through FACS, compared with measurements in normal CD19+ B-cells and monocytes, confirmed that a subset of CLL aberrantly expresses high INSR levels.Overall design: We have employed integrated genomic profiling approaches upon CLL cases with and without del11q to identify 11q-relevant genes.Included are 10 primary human cases with del11q and 9 cases without del11q
Data type: Transcriptome or Gene expression
Sample scope: Multiisolate
Relevance: Medical
Organization: Internal Medicine, Hematology-Oncology, University of Michigan
Literatures
- PMID: 21307146
Release date: 2011-05-06
Last updated: 2011-01-10